Well-Differentiated Liposarcoma of the Retroperitoneum with Dedifferentiation and Multiple Recurrences: Case Report

Authors

  • Ivna Silva Gonçalves Instituto do Câncer do Ceará (ICC), Hospital Haroldo Juaçaba (HHJ). Fortaleza (CE), Brasil. https://orcid.org/0000-0002-1144-4614
  • Davi Teixeira de Macêdo Universidade Federal do Ceará (UFC), Faculdade de Medicina. Fortaleza (CE), Brasil. https://orcid.org/0000-0002-4193-7700
  • Iasmin Maria Rodrigues Saldanha Universidade Federal do Ceará (UFC), Faculdade de Medicina. Fortaleza (CE), Brasil. https://orcid.org/0000-0002-3719-8175
  • Lívia Fernandes e Silva Universidade Federal do Ceará (UFC), Faculdade de Medicina. Fortaleza (CE), Brasil. https://orcid.org/0000-0002-2035-2287
  • Paulo Henrique Silva Nunes Universidade Federal do Ceará (UFC), Faculdade de Medicina. Fortaleza (CE), Brasil. https://orcid.org/0000-0002-9591-1012
  • Gunter Gerson Universidade Federal do Ceará (UFC), Hospital Universitário Walter Cantídio. Fortaleza (CE), Brasil. https://orcid.org/0000-0001-9054-253X
  • Marcelo Leite Vieira Costa Universidade Federal do Ceará (UFC), Hospital Universitário Walter Cantídio. Fortaleza (CE), Brasil. https://orcid.org/0000-0002-1343-4292
  • Irapuan Teles de Araújo Filho Universidade Federal do Ceará (UFC), Hospital Universitário Walter Cantídio. Fortaleza (CE), Brasil. https://orcid.org/0000-0001-8935-7994

DOI:

https://doi.org/10.32635/2176-9745.RBC.2023v69n3.3626

Keywords:

liposarcoma, retroperitoneal neoplasms, recurrence, cell dedifferentiation, surgical oncology

Abstract

Introduction: Retroperitoneal liposarcomas are rare mesenchymal neoplasms, with well-differentiated and dedifferentiated liposarcomas being most common. The well differentiated subtype can undergo dedifferentiation to higher grade tumors. These are difficult neoplasms to treat surgically because they have high rates of local recurrence, some subtypes can metastasize, and are poorly responsive to radiotherapy and chemotherapy. Case report: Female patient, 45 years old, presented abdominal pain and palpable abdominal mass in 2017. She underwent resection of well-differentiated liposarcoma of the retroperitoneum, without intercurrences. In 2020, she manifested abdominal pain and weight loss. Tomography showed multiple voluminous abdominal masses, with biopsy suggestive of dedifferentiated liposarcoma. The patient was submitted to neoadjuvant radiotherapy, followed by surgical resection of the masses and right ileocolectomy. In 2022, she presented symptoms suggestive of intestinal obstruction, and underwent laparotomy that revealed intense blockage of intestinal loops, duodenal fistula, retroperitoneal tumor, and fecal peritonitis. Retroperitoneal neoplasm resection, ileostomy and fistula closure were performed. Histopathology showed relapsed dedifferentiated liposarcoma. The patient evolved with operative and infectious complications, requiring intensive care and antibiotic therapy. After clinical improvement, the patient was discharged with enteral diet and continues under outpatient follow-up. Conclusion: Retroperitoneal liposarcoma may undergo multifocal dedifferentiation and recurrence, requiring several surgical approaches, increasing morbidity and the risk of complications. Wide margin surgery remains the main therapeutic modality.

Downloads

Plum Print visual indicator of research metrics
  • Captures
  • Mendeley - Readers: 1
-
see details

References

Haddox CL, Riedel RF. Recent advances in the understanding and management of liposarcoma. Fac Rev. 2021;10:1. doi: https://doi.org/10.12703/r/10-1 DOI: https://doi.org/10.12703/r/10-1

Matthyssens LE, Creytens D, Ceelen WP. Retroperitoneal liposarcoma: current insights in diagnosis and treatment. Front Surg. 2015;2:4. doi: https://doi.org/10.3389/fsurg.2015.00004 DOI: https://doi.org/10.3389/fsurg.2015.00004

Chamberlain F, Benson C, Thway K, et al. Pharmacotherapy for liposarcoma: current and emerging synthetic treatments. Future Oncol. 2021;17(20):2659-70. doi: https://doi.org/10.2217/fon-2020-1092 DOI: https://doi.org/10.2217/fon-2020-1092

Tyler R, Wanigasooriya K, Taniere P, et al. A review of retroperitoneal liposarcoma genomics. Cancer Treat Rev. 2020;86:102013. doi: https://doi.org/10.1016/j.ctrv.2020.102013 DOI: https://doi.org/10.1016/j.ctrv.2020.102013

Mack T, Purgina B. Updates in pathology for retroperitoneal soft tissue sarcoma. Curr Oncol. 2022;29(9):6400-18. doi: https://doi.org/10.3390/curroncol29090504 DOI: https://doi.org/10.3390/curroncol29090504

Bagaria SP, Gabriel E, Mann GN. Multiply recurrent retroperitoneal liposarcoma. J Surg Oncol. 2018;117(1):62-8. doi: https://doi.org/10.1002/jso.24929 DOI: https://doi.org/10.1002/jso.24929

Conselho Nacional de Saúde (BR). Resolução nº 466, de 12 de dezembro de 2012. Aprova as diretrizes e normas regulamentadoras de pesquisas envolvendo seres humanos. Diário Oficial da União, Brasília, DF. 2013 jun 13; Seção 1:59.

Mansfield SA, Pollock RE, Grignol VP. Surgery for abdominal well-differentiated liposarcoma. Curr Treat Options Oncol. 2018;19(1):1. doi: https://doi.org/10.1007/s11864-018-0520-6 DOI: https://doi.org/10.1007/s11864-018-0520-6

Nishio J, Nakayama S, Nabeshima K, et al. Biology and management of dedifferentiated liposarcoma: state of the art and perspectives. J Clin Med. 2021;10(15):3230. doi: https://doi.org/10.3390/jcm10153230 DOI: https://doi.org/10.3390/jcm10153230

Crago AM, Dickson MA. Liposarcoma: multimodality management and future targeted therapies. Surg Oncol Clin N Am. 2016;25(4):761-73. doi: https://doi.org/10.1016/j.soc.2016.05.007 DOI: https://doi.org/10.1016/j.soc.2016.05.007

Downloads

Published

2023-07-14

How to Cite

1.
Gonçalves IS, Macêdo DT de, Saldanha IMR, Silva LF e, Nunes PHS, Gerson G, Costa MLV, Araújo Filho IT de. Well-Differentiated Liposarcoma of the Retroperitoneum with Dedifferentiation and Multiple Recurrences: Case Report. Rev. Bras. Cancerol. [Internet]. 2023 Jul. 14 [cited 2025 Apr. 1];69(3):e-093626. Available from: https://rbc.inca.gov.br/index.php/revista/article/view/3626

Issue

Vol. 69 No. 3 (2023): July/Aug./Sept.

Section

CASE REPORT

License

Os direitos morais e intelectuais dos artigos pertencem aos respectivos autores, que concedem à RBC o direito de publicação.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Most read articles by the same author(s)